DURECT Stock

DURECT Liabilities 2024

DURECT Liabilities

30.41 M USD

Ticker

DRRX

ISIN

US2666051048

WKN

564868

In 2024, DURECT's total liabilities amounted to 30.41 M USD, a -13.37% difference from the 35.1 M USD total liabilities in the previous year.

DURECT Aktienanalyse

What does DURECT do?

DURECT Corporation is a US pharmaceutical company specializing in the development and marketing of innovative drugs for chronic pain, neurological disorders, and metabolic disorders. They have a broad portfolio of products based on various technologies and platforms, including Parenteral Controlled Release (PCR), Transdermal Delivery Systems (TDS), and Oral Sustained Release (OSR). They have developed technologies such as PCR for slow drug release, TDS for drug administration through the skin, and OSR for sustained-release tablets. DURECT has partnerships with notable pharmaceutical companies such as Pfizer, Sandoz, Zogenix, and Janssen Pharmaceutica, allowing them to distribute their products in a wider market and expand internationally. Their goal is to continue strengthening their position as a leading company in the industry and expanding their product range. DURECT ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing DURECT's Liabilities

DURECT's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating DURECT's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing DURECT's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

DURECT's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in DURECT’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about DURECT stock

What is the level of liabilities of DURECT this year?

DURECT has a debt balance of 30.41 M USD this year.

What were the liabilities of DURECT compared to the previous year?

The liabilities of DURECT have increased by -13.37% dropped compared to the previous year.

What are the consequences of high debt for investors of DURECT?

High liabilities can pose a risk for investors of DURECT, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in DURECT?

Low liabilities mean that DURECT has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of DURECT affect the company?

An increase in liabilities of DURECT can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of DURECT affect the company?

A decrease in the liabilities of DURECT can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of DURECT?

Some factors that can influence the liabilities of DURECT include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of DURECT so important for investors?

The liabilities of DURECT are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can DURECT take to modify the liabilities?

To change its liabilities, DURECT can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does DURECT pay?

Over the past 12 months, DURECT paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DURECT is expected to pay a dividend of 0 USD.

What is the dividend yield of DURECT?

The current dividend yield of DURECT is .

When does DURECT pay dividends?

DURECT pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of DURECT?

DURECT paid dividends every year for the past 0 years.

What is the dividend of DURECT?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is DURECT located?

DURECT is assigned to the 'Health' sector.

Wann musste ich die Aktien von DURECT kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DURECT from 8/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/27/2024.

When did DURECT pay the last dividend?

The last dividend was paid out on 8/27/2024.

What was the dividend of DURECT in the year 2023?

In the year 2023, DURECT distributed 0 USD as dividends.

In which currency does DURECT pay out the dividend?

The dividends of DURECT are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The DURECT stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von DURECT

Our stock analysis for DURECT Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DURECT Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.